UBS analyst Alex Kramm lowered the firm’s price target on MarketWise to $2 from $3.50 and keeps a Neutral rating on the shares. UBS remains on the sidelines on MarketWise given increased uncertainty, and while the company has done a solid job on driving increased profitability, billings and paid subscribers have continued to decline, and given significant headcount reductions and the wind-down of the Legacy Research Group, the firm has less confidence in the outlook, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MKTW:
